Vaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical length.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data.American journal of obstetrics and gynecology · 2018
   Pooled it
2. Risk factors for spontaneous preterm birth are mediated through changes in cervical length.Communications medicine · 2025
   Article
3. Study protocol to quantify the genetic architecture of sonographic cervical length and its relationship to spontaneous preterm birth.BMJ open · 2022
   Article
4. Progesterone for the Prevention of Preterm Birth - an Update of Evidence-Based Indications.Geburtshilfe und Frauenheilkunde · 2019
   Article
5. Preterm birth: seven-year retrospective study in a single centre population.Italian journal of pediatrics · 2019
   Observational
6. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.American journal of obstetrics and gynecology · 2016
   Article
7. Progesterone to prevent spontaneous preterm birth.Seminars in fetal & neonatal medicine · 2014
   Review
8. Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy.International journal of women's health · 2012
   Article

Corrections and comments

• Commented on by
  What is new in preterm birth prevention? Important recent articles.2013
• Comment on
  Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as